Chemical Structure (Flovent Diskus Spl Graphic 01)
Flovent Powder, Metered
Product Images NDC 63187-957
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Flovent (NDC 63187-957). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. A 12-week Clinical Trial Evaluating Flovent Diskus 100 Mcg Twice Daily In Adults And Adolescents Receiving Bronchodilators Alone (Flovent Diskus Spl Graphic 02)
This is a chart showing the change in FEV1 (Forced Expiratory Volume in 1 second) over 12 weeks for patients using FLOVENT DISKUS 100 mcg twice daily compared to those using placebo. The baseline FEV1 for the group using FLOVENT DISKUS was 2.60 L and 2.62 L for the placebo group. The chart shows a gradual increase in FEV1 for the FLOVENT DISKUS group, with an endpoint change of approximately 0.25 L from baseline.*
Figure 2. A 12-week Clinical Trial Evaluating Flovent Diskus 100 Mcg Twice Daily In Adults And Adolescents Receiving Inhaled Corticosteroids (Flovent Diskus Spl Graphic 03)
Figure 3. A 12-week Clinical Trial Evaluating Flovent Diskus 250 Mcg Twice Daily In Adults And Adolescents Receiving Inhaled Corticosteroids Or Bronchodilators Alone (Flovent Diskus Spl Graphic 04)
The text represents a chart or a graph that displays the % Change from Baseline in FEV1 for Flovent Diskus 250 mcg and Placebo. There is no useful information available about the % change.*
Figure 4. A 12-week Clinical Trial Evaluating Flovent Diskus 500 Mcg Twice Daily In Adults And Adolescents Receiving Inhaled Corticosteroids Or Bronchodilators Alone (Flovent Diskus Spl Graphic 05)
This is a chart representing the change from baseline in FEV1 for Flovent Diskus 500mcg taken twice a day compared to a placebo. The data is presented over 12 intervals, with the endpoint being the final interval. There is no additional information available.*
Figure A (Flovent Diskus Spl Graphic 06)
The text input appears to provide information on two separate components of an object. The first component is the "Outer Case" while the second component is the "Mouthpiece" with a feature called "Thumb Grip". Unfortunately, no further context or details are available to make any assumptions on what specific object these components belong to or their purpose.*
Figure B (Flovent Diskus Spl Graphic 07)
Figure C (Flovent Diskus Spl Graphic 08)
Figure D (Flovent Diskus Spl Graphic 09)
Figure E (Flovent Diskus Spl Graphic 10)
Figure F (Flovent Diskus Spl Graphic 11)
Figure G (Flovent Diskus Spl Graphic 12)
Figure H (Flovent Diskus Spl Graphic 13)
63187-957-60 (Flovent Diskus Spl Graphic 15)
This is a description of an inhaler medication labeled as Flovent Diskus 100mcg manufactured by GlaxoSmithKline, containing 60 inhalers per package. Each inhaler contains 100mcg of fluticasone propionate with lactose intended for oral inhalation only. This medication should be stored at a temperature between 68°F and 77°F (20°C and 25°C) and should be kept out of the reach of children. This product is relabeled by Proficient Rx LP based in Thousand Oaks, CA. Package details include product ID: RF095760 and lot number: 00000. However, there are three different types of inhalers under SN# MASTER, SNEMASTER, and SNAMASTER, each bearing the same NDC code 63187-957-60, lot number, and expiration date.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
